Nephurocare Pharma Private Limited - Company Profile

It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2010.
2010 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Nephurocare Pharma Private Limited

Nephurocare Pharma Private Limited, a active private limited company, was established on 11 November 2010 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230GJ2010PTC062880. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.

Formerly known as Nerve Biosciences Private Limited. It upholds a compliant status. Employing 21 professional, Its leadership includes Snehal Narendraprasad Vaishnav (Director), Viral Narendrabhai Shah (Director), Sandip Kulkarni Sureshrav (Director). Past directors included Bijjala Kavitha, Indravadan Pranshanker Bhatt, Bhumiben Satyajit Bhatt. It holds ₹2.20 Cr open charges and ₹1.10 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 301, Gold Leaf, Maradia Plaza Lane, Behind Law College, Off C.G. Road, Navra, Ngpura, Ahmedabad, Gujarat, 380009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230GJ2010PTC062880

  • Registration Number

    062880

  • Incorporation Date

    11 November 2010

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 3.00 M
  • Company Age 15 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.20 Cr
  • Satisfied Charges ₹ 1.10 Cr
  • Revenue Growth **** 12.86%
  • Profit Growth **** -2.19%
  • Ebitda **** 98.94%
  • Net Worth 7.53%
  • Total Assets **** 9.48%
Company report

Nephurocare Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nephurocare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nephurocare Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Snehal Narendraprasad Vaishnav Director 04 Sep 2014 Current
Viral Narendrabhai Shah Director 04 Sep 2014 Current
Sandip Kulkarni Sureshrav Director 18 Sep 2014 Current
Jashvant Patel Prahladbhai Director 10 Sep 2014 Current
Shailesh Joshi Rameshchandra Director 01 Apr 2015 Current
Satyajit Indravadan Bhatt Director 01 Mar 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Apr 2017 Past
Pramod Abcsdd Director 17 Sep 2012 Past
Pramod Abcsdd Director 01 Dec 2014 Past
Pramod Abcsdd Director 15 Jun 2013 Past
Pramod Abcsdd Director 13 Feb 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nephurocare Pharma.

Nephurocare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.86% increase. The company also saw a slight decrease in profitability, with a 2.19% decrease in profit. The company's net worth moved up by a moderate rise of 7.53%.

Nephurocare Pharma revenue growth over time
Nephurocare Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.86%
*******
*******
*******
*******
Revenue from Operations
*******
 13.81%
*******
*******
*******
*******
Total Assets
*******
 9.48%
*******
*******
*******
*******
Profit or Loss
*******
 -2.19%
*******
*******
*******
*******
Net Worth
*******
 7.53%
*******
*******
*******
*******
EBITDA
*******
 98.94%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nephurocare Pharma?

In 2023, Nephurocare Pharma had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹22,000,000.00

Satisfied Charges

₹11,020,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 2.20 Cr
Latest Charge Details
Date Lender Amount Status
04 Oct 2023 Hdfc Bank Limited ₹7.00 M Open
15 Jun 2023 Hdfc Bank Limited ₹1.50 Cr Open
28 Nov 2017 Others ₹7.02 M Satisfied
01 Mar 2017 Others ₹4.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Nephurocare Pharma?

Nephurocare Pharma has a workforce of 21 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nephurocare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephurocare Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nephurocare Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Nephurocare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Nephurocare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 15.00 M registered on 15 Jun 2023 with Charge ID 100769132 was modified on 12 Dec 2023. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 7.00 M with Charge ID 100819336 was registered on 04 Oct 2023. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 15.00 M with Charge ID 100769132 was registered on 15 Jun 2023. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 28 Nov 2017 via Charge ID 100140522 with Others was fully satisfied on 15 Jun 2023. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nephurocare Pharma Private Limited?

The CIN of Nephurocare Pharma Private Limited is U24230GJ2010PTC062880.

Where is Nephurocare Pharma Private Limited headquartered?

Nephurocare Pharma Private Limited is headquartered at 301, Gold Leaf, Maradia Plaza Lane, Behind Law College, Off C.G. Road, Navra, Ngpura, Ahmedabad, Gujarat, 380009.

When was Nephurocare Pharma Private Limited incorporated?

Nephurocare Pharma Private Limited was incorporated on 11 November 2010.

Who are the current directors of Nephurocare Pharma Private Limited?

The current directors of Nephurocare Pharma Private Limited are

What is the primary industry of Nephurocare Pharma Private Limited?

The primary industry of Nephurocare Pharma Private Limited is Trade.

Is Nephurocare Pharma Private Limited a listed company?

Nephurocare Pharma Private Limited is unlisted.

What is the capital structure of Nephurocare Pharma Private Limited?

The authorized capital of Nephurocare Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.

What is the compliance status of Nephurocare Pharma Private Limited?

The compliance status of Nephurocare Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available